Please login to the form below

Not currently logged in
Email:
Password:

cystic fibrosis

This page shows the latest cystic fibrosis news and features for those working in and with pharma, biotech and healthcare.

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

Vertex Pharmaceuticals, a biotech known for its clinical development programmes in cystic fibrosis, has appointed a new chief medical officer in the form of Reshma Kewalramani. ... I look forward to working with her to continue to advance our clinical

Latest news

More from news
Approximately 19 fully matching, plus 89 partially matching documents found.

Latest Intelligence

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    Cystic fibrosis is one of the conditions where our understanding of genomics is transforming treatment and care. ... We recognise the situation with cystic fibrosis in the UK needs a unique solution.

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    Cystic fibrosis is one of the conditions where our understanding of genomics is transforming treatment and care. ... We recognise the situation with cystic fibrosis in the UK needs a unique solution.

  • Significant figures Significant figures

    NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    The research includes those diseases that are rare and neglected such as cystic fibrosis, a condition that has a devastating effect on patients, families and carers.

  • Deal Watch March 2017 Deal Watch March 2017

    CTP-656 is a CFTR potentiator in development as part of a combination regimen in cystic fibrosis patients. ... 250. Concert Pharmaceuticals. Vertex Pharmaceuticals. Product acquisition. CTP-656 for cystic fibrosis in phase II.

More from intelligence
Approximately 2 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Patient Perspective - Cystic Fibrosis

    Patient Perspective - Cystic Fibrosis. At Synergy Vision, we aim to make a difference to patients. ... In the second video in our series on patient perspectives we are talking about cystic fibrosis.

  • Synergy Vision MD appointed as trustee of the Cystic Fibrosis Trust

    Managing director of Synergy Vision Ffyona Dawber has been appointed to the Cystic Fibrosis Trust’ s board of trustees. ... I have both friends and family living with cystic fibrosis, each of whom have inspired me to raise awareness about the real-life

  • 500 miles over 5 days - 2 brave cyclists!

    Synergy Vision are cycling from their London headquarters to their Dublin office, and will be travelling about 500 miles to raise money for two very worthwhile charities: The Cystic Fibrosis Trust

  • Celebrities communicating a health or charity message by Jenny Agutter

    I have worked longest with The  Cystic Fibrosis Trust after finding out 35 years ago, when my niece was born, that she had the life threatening condition Cystic Fibrosis. ... She was a friend and this annual Christmas carol concert is a wonderful way to

More from PMHub
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics